- Home
- SCD vs CYRX Comparison
SCD vs CYRX Comparison
Compare SCD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCD | CYRX |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.2M | 421.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | SCD | CYRX |
|---|---|---|
| Price | $14.84 | $8.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 37.5K | ★ 398.8K |
| Earning Date | 01-01-0001 | 03-03-2026 |
| Dividend Yield | ★ 9.63% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $10.92 |
| Revenue Next Year | N/A | $8.08 |
| P/E Ratio | ★ N/A | $5.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.35 | $4.63 |
| 52 Week High | $16.89 | $11.45 |
Technical Indicators
Market Signals| Indicator | SCD | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.14 | 43.61 |
| Support Level | $14.65 | $8.01 |
| Resistance Level | $15.11 | $8.45 |
| Average True Range (ATR) | 0.33 | 0.53 |
| MACD | -0.09 | 0.06 |
| Stochastic Oscillator | 0.79 | 24.57 |
Price Performance
Historical ComparisonAbout SCD LMP Capital and Income Fund Inc.
Lmp Capital & Income Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is total return with an emphasis on income. The fund invests in a broad range of equity and fixed-income securities of both the U.S. and foreign issuers. Its long-term investments consists of investments in common stocks, convertible preferred stocks, investments in underlying funds and master limited partnerships. Maximum investment in Sales in the IT sector, Cheniere Energy in the energy sector, Ares Management and U.S. Bancorp in the financials sector and Lennar in the consumer discretionary sector, and etc.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.